The Potential Future Impact of CAR T Cell Therapy in Adult ALL
Experts in hematology oncology consider unmet needs for adult patients with relapsed/refractory ALL and reflect on the potential impact that FDA approval of CAR T cell therapy would have on the treatment landscape.
EP: 1.The Evolving Treatment Landscape for ALL
EP: 2.Using MRD to Monitor Therapeutic Response in ALL
EP: 3.The ZUMA-3 Trial: Study Design and Patient Population
EP: 4.The ZUMA-3 Trial: Efficacy and Safety Results
EP: 5.The ZUMA-3 Trial: Clinical Endpoints
Now Viewing
EP: 6.The Potential Future Impact of CAR T Cell Therapy in Adult ALL
Related Videos
Related Content
